STOCK TITAN

Allied Motion Reports Record Operating Income on Revenue of $134.4 Million in Third Quarter 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Allied Motion Technologies (Nasdaq: AMOT) reported a record revenue of $134.4 million for Q3 2022, marking a 30% increase year-over-year, driven by a 15% organic growth rate. Gross margin improved to 32.2%, an increase of 130 basis points, and operating income rose 35% to $11.7 million. The net income was $6.6 million, or $0.41 per share. The company emphasized strong execution in leveraging both organic and acquisition growth strategies to navigate ongoing macroeconomic challenges.

Positive
  • Record Q3 revenue of $134.4 million, up 30% YoY.
  • Gross margin increased to 32.2%, up 130 basis points.
  • Operating income grew 35% to $11.7 million.
  • Net income reached $6.6 million, or $0.41 per share.
  • Adjusted net income per share rose 22% to $0.60.
Negative
  • Operating costs increased to 23.5% of revenue, up 90 basis points.
  • Net income decrease compared to prior year, reflecting a discrete tax benefit previously recorded.
  • Revenue grew 30% to a record $134.4 million, with organic growth of 15% on a constant currency basis
  • Gross margin expanded 130 basis points to 32.2% year-over-year as higher volume, recent acquisitions and pricing more than offset ongoing supply chain disruptions and material and labor inflation
  • Operating income grew 35% to a record $11.7 million with a margin of 8.7%, which was up

    30 basis points due to operating leverage
  • Achieved net income of $6.6 million or $0.41 per diluted share
  • Adjusted net income per share was $0.60, up 22%

AMHERST, N.Y.--(BUSINESS WIRE)-- Allied Motion Technologies Inc. (Nasdaq: AMOT) (“Allied Motion” or “Company”), a designer and manufacturer of precision and specialty controlled motion products and solutions for the global market, today reported financial results for its third quarter ended September 30, 2022. Results include all acquisitions completed during the fourth quarter of 2021 and in the second quarter of 2022.

“Results in the quarter demonstrated the power of our strategy combined with strong execution to drive both organic and inorganic growth, as we leveraged our diversified end market mix, and further developed our One Allied global platform to drive record sales. Equally important, was the strengthening of our margin profile, which delivered record operating income despite ongoing macroeconomic headwinds,” commented Dick Warzala, Chairman and CEO. “We continue to be highly confident in our ability to navigate today’s unique challenges and expect to see further benefits as we further leverage the full potential of our recent acquisitions and create a stronger long term competitive position across our targeted markets.”

Third Quarter 2022 Results (Narrative compares with prior-year period unless otherwise noted)

Revenue increased 30% to a record $134.4 million and reflected higher demand across each of the Company’s target markets, as well as incremental sales from acquisitions. Excluding the unfavorable impact of foreign currency exchange rate fluctuations on revenue of $7.2 million, revenue was up 37%, including organic growth of 15%. Sales to U.S. customers were 59% of total sales compared with 56% in the same period last year, with the balance of sales to customers primarily in Europe, Canada and Asia-Pacific. See the attached table for a description of non-GAAP financial measures and reconciliation of revenue excluding foreign currency exchange rate fluctuations.

Aerospace & Defense revenue grew 159% due to incremental demand from acquisitions, defense program timing and solid organic growth. Revenue from Industrial markets was up 39% in the quarter, benefitting from new solutions offerings, acquisitions and strong end market demand within industrial automation, pumps, and oil & gas. Revenue in the Vehicle and Medical markets each grew 4%. Vehicle market sales growth reflected higher demand from commercial automotive and trucks, while Medical markets have now largely lapped pandemic related sales and are benefiting from a return of elective surgeries and recent acquisitions. The Distribution market, while a small component of total revenue, increased 25% during the quarter.

Gross margin was 32.2%, up 130 basis points from the third quarter of 2021 as higher volume, pricing and margin accretive acquisitions more than offset continued global supply chain disruptions, and rising material and labor costs.

Operating costs and expenses were 23.5% of revenue, up 90 basis points, which reflected an increase in engineering and development costs of approximately 70 basis points, and amortization expense of 80 basis points, largely due to the recent M&A activity. Partially offsetting were lower selling, general and administrative expenses as a percent of revenue due to operating leverage. As a result, operating income was a record $11.7 million compared with $8.7 million, and as a percent of revenue was 8.7%, up 30 basis points.

Net income was $6.6 million, or $0.41 per diluted share, compared to $6.0 million, or $0.41 per share, in the prior-year period. Adjusted net income, which excludes amortization of intangible assets related to acquisitions, business development costs and other non-recurring items, was $9.7 million, or $0.60 per diluted share, compared with adjusted net income of $7.1 million, or $0.49 per diluted share, in the comparable period of 2021. The effective tax rate was 27.5% compared with 24.6%, as the prior-year period included a discrete benefit for an investment tax credit. The Company expects its income tax rate for full year 2022 to be approximately 25% to 27%, based on changes to geographic mix. See the attached tables for a description of non-GAAP financial measures and reconciliation table for Adjusted Net Income and Diluted Earnings per Share.

Earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, business development costs, and foreign currency gains/losses (“Adjusted EBITDA”) was $19.9 million, up $5.4 million, or 37% from the year ago period. As a percent of sales, Adjusted EBITDA was 14.8%, up 80 basis points from the third quarter of 2021. The Company believes that, when used in conjunction with measures prepared in accordance with U.S. generally accepted accounting principles, Adjusted EBITDA, which is a non-GAAP measure, helps in the understanding of its operating performance. See the attached table for a description of non-GAAP financial measures and reconciliation table for Adjusted EBITDA.

Year-to-Date (YTD) 2022 Results (Narrative compares with prior-year period unless otherwise noted)

Revenue of $371.9 million increased $65.2 million, or 21%, reflecting strong demand in Industrial and Aerospace & Defense markets, including incremental sales from acquisitions. The impact of FX fluctuations was unfavorable $15.6 million for the year-to-date period. Sales to U.S. customers were 58% of total sales compared with 54% for the same period last year, with the balance of sales to customers primarily in Europe, Canada and Asia-Pacific.

Gross margin was 31.3%, up 90 basis points, and reflected similar impacts as the third quarter of 2022. Operating costs and expenses as a percent of revenue were 25.0%, up 180 basis points, due to similar impacts as the third quarter as well as higher business development costs in support of recent M&A activity. As a result, operating income was $23.5 million, or 6.3% of sales, compared with $22.0 million, or 7.2% of sales.

Net income was $13.7 million, or $0.86 per diluted share, compared with $22.5 million, or $1.56 per diluted share. The change largely reflects a net discrete tax benefit of $7.4 million recorded in the first quarter of 2021 relating to legislation enacted in New Zealand. Excluding the discrete tax benefit, amortization of intangible assets and other non-recurring items, adjusted net income was $23.0 million, or $1.45 per diluted share, compared with $18.8 million, or $1.30 per diluted share, in the comparable period of 2021. Adjusted EBITDA increased 26% to $49.0 million, and as a percent of sales was 13.2%, up 50 basis points.

Balance Sheet and Cash Flow Review

Cash and cash equivalents were $19.7 million compared with $22.5 million at year-end 2021. Higher levels of inventory and working capital timing resulted in $5.8 million of cash used in operating activities during the year-to-date period. Capital expenditures were $11.0 million for the year-to-date period and were largely focused on new customer projects. The Company expects 2022 capital expenditures to be approximately $14 million to $18 million.

Total debt was $231.9 million at quarter-end compared with $159.0 million at year-end 2021. The change largely reflected the funding used for the three acquisitions completed during the second quarter of 2022 and a new finance lease during the first quarter of 2022 for a manufacturing facility expansion. Debt, net of cash, was $212.2 million, or 51.3% of net debt to capitalization.

Orders and Backlog Summary ($ in thousands)

Q3 2022

Q2 2022

Q1 2022

Q4 2021

Q3 2021

Orders

$

126,158

$

139,209

$

155,295

$

114,891

$

119,940

Backlog

$

310,186

$

323,873

$

289,295

$

249,927

$

185,561

Third quarter orders increased 5% year-over-year and represented a book-to-bill ratio of 0.94x. Foreign currency translation had an unfavorable $7.3 million impact on third quarter orders compared with the prior-year period.

Backlog was up 67% over the prior-year period, although was down 4% from the sequential second quarter given the loosening of some supply chain constraints. The time to convert the majority of backlog to sales is approximately three to nine months.

Conference Call and Webcast

The Company will host a conference call and webcast on Thursday, November 3, 2022 at 10:00 am ET.

During the conference call, management will review the financial and operating results and discuss Allied Motion’s corporate strategy and outlook. A question and answer session will follow.

To listen to the live call, dial (412) 317-6026. In addition, the webcast and slide presentation may be found at: www.alliedmotion.com/investor-relations.

A telephonic replay will be available from 1:00 pm ET on the day of the call through Thursday, November 10, 2022.

To listen to the archived call, dial (412) 317-6671 and enter replay pin number 10171521 or access the webcast replay via the Company’s website. A transcript will also be posted to the website once available.

About Allied Motion Technologies Inc.

Allied Motion (Nasdaq: AMOT) designs, manufactures and sells precision controlled motion products and solutions used in a broad range of applications within the Vehicle, Medical, Aerospace & Defense, Electronic, and Industrial Markets. Headquartered in Amherst, NY, the Company has global operations and sells into markets across the United States, Canada, South America, Europe and Asia-Pacific.

Allied Motion is focused on controlled motion applications and is known worldwide for its expertise in electro-magnetic, mechanical, and electronic controlled motion technologies. Its products include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor-drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues, lightweighting technologies, Industrial safety rated I/O Modules, Universal Industrial Communications Gateways and other controlled motion-related products.

The Company’s growth strategy is focused on being the controlled motion solutions leader in its selected target markets by leveraging its “technology/know how” to develop integrated precision solutions that utilize multiple Allied Motion technologies to “change the game” and create higher value solutions for its customers. The Company routinely posts news and other important information on its website at www.alliedmotion.com.

Safe Harbor Statement

The statements in this news release and in the Company’s November 3, 2022 conference call that relate to future plans, events or performance are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements. Examples of forward-looking statements include, among others, statements the Company makes regarding expected operating results, anticipated levels of capital expenditures, the Company’s belief that it has sufficient liquidity to fund its business operations, and expectations with respect to the conversion of backlog to sales. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, general economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company's customers and suppliers, competitor responses to the Company's products and services, the overall market acceptance of such products and services, the pace of bookings relative to shipments, the ability to expand into new markets and geographic regions, the success in acquiring new business, the impact of changes in income tax rates or policies, the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses’ and governments’ responses to the pandemic on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains; our inability to predict the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives, the ability to attract and retain qualified personnel, the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems, and other factors disclosed in the Company's periodic reports filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward looking statements, whether as a result of new information, future events, or otherwise.

FINANCIAL TABLES FOLLOW

 

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

 

For the three months ended

 

For the nine months ended

September 30,

 

September 30,

 

2022

 

2021

 

2022

 

2021

Revenue

$

134,405

$

103,509

$

371,912

$

306,723

Cost of goods sold

 

91,108

 

71,488

 

255,381

 

213,417

Gross profit

 

43,297

 

32,021

 

116,531

 

93,306

Operating costs and expenses:

Selling

 

5,497

 

4,365

 

16,336

 

12,979

General and administrative

 

13,148

 

10,620

 

37,239

 

32,549

Engineering and development

 

9,702

 

6,768

 

28,879

 

20,967

Business development

 

199

 

94

 

2,464

 

268

Amortization of intangible assets

 

3,054

 

1,504

 

8,133

 

4,527

Total operating costs and expenses

 

31,600

 

23,351

 

93,051

 

71,290

Operating income

 

11,697

 

8,670

 

23,480

 

22,016

Other expense, net:

Interest expense

 

2,337

 

777

 

4,900

 

2,445

Other expense (income), net

 

243

 

(29)

 

9

 

(158)

Total other expense, net

 

2,580

 

748

 

4,909

 

2,287

Income before income taxes

 

9,117

 

7,922

 

18,571

 

19,729

Income tax (provision) benefit

 

(2,508)

 

(1,950)

 

(4,878)

 

2,804

Net income

$

6,609

$

5,972

$

13,693

$

22,533

Basic earnings per share:

Earnings per share

$

0.42

$

0.41

$

0.89

$

1.57

Basic weighted average common

shares

 

15,661

 

14,411

 

15,373

 

14,375

Diluted earnings per share:

Earnings per share

$

0.41

$

0.41

$

0.86

$

1.56

Diluted weighted average

common shares

 

16,169

 

14,502

 

15,929

 

14,478

 

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

 

September 30,

 

December 31,

 

2022

 

2021

Assets

 

 

 

 

 

Current assets:

Cash and cash equivalents

$

19,705

$

22,463

Trade receivables, net of provision for credit losses of $790 and $506

at September 30, 2022 and December 31, 2021, respectively

79,894

51,239

Inventories

 

112,130

 

89,733

Prepaid expenses and other assets

 

15,426

 

12,522

Total current assets

 

227,155

 

175,957

Property, plant and equipment, net

 

65,617

 

56,983

Deferred income taxes

 

3,460

 

5,321

Intangible assets, net

 

120,773

 

103,786

Goodwill

 

122,404

 

106,633

Operating lease assets

21,623

16,983

Other long-term assets

 

11,488

 

5,122

Total Assets

$

572,520

$

470,785

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

41,955

$

36,714

Accrued liabilities

 

46,135

 

41,656

Total current liabilities

 

88,090

 

78,370

Long-term debt

 

231,647

 

158,960

Deferred income taxes

 

8,910

 

5,040

Pension and post-retirement obligations

 

3,523

 

3,932

Operating lease liabilities

17,644

12,792

Other long-term liabilities

 

21,609

23,929

Total liabilities

 

371,423

 

283,023

Stockholders’ Equity:

Common stock, no par value, authorized 50,000 shares; 15,982 and

15,361 shares issued and outstanding at September 30, 2022 and

December 31, 2021, respectively

 

82,830

 

68,097

Preferred stock, par value $1.00 per share, authorized 5,000 shares;

no shares issued or outstanding

 

 

Retained earnings

 

140,277

 

127,757

Accumulated other comprehensive loss

 

(22,010)

 

(8,092)

Total stockholders’ equity

 

201,097

 

187,762

Total Liabilities and Stockholders’ Equity

$

572,520

$

470,785

 

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

For the nine months ended

September 30,

 

2022

 

2021

Cash Flows From Operating Activities:

Net income

$

13,693

$

22,533

Adjustments to reconcile net income to net cash (used in) provided by operating activities

Depreciation and amortization

 

19,222

 

13,317

Deferred income taxes

 

2,775

 

(7,440)

Stock-based compensation expense

3,752

3,100

Debt issue cost amortization recorded in interest expense

127

106

Other

 

785

 

1,235

Changes in operating assets and liabilities, net of acquisition:

Trade receivables

 

(27,560)

 

(9,586)

Inventories

 

(25,782)

 

(11,747)

Prepaid expenses and other assets

 

(3,133)

 

(675)

Accounts payable

 

6,501

 

8,168

Accrued liabilities

 

3,796

 

909

Net cash (used in) provided by operating activities

 

(5,824)

 

19,920

 

Cash Flows From Investing Activities:

Consideration paid for acquisitions, net of cash acquired

 

(44,596)

 

Purchase of property and equipment

 

(11,026)

 

(9,761)

Net cash used in investing activities

 

(55,622)

 

(9,761)

 

Cash Flows From Financing Activities:

Proceeds from issuance of long-term debt

 

69,952

 

819

Principal payments of long-term debt and finance lease obligations

(6,514)

(11,417)

Dividends paid to stockholders

 

(1,147)

 

(1,007)

Tax withholdings related to net share settlements of restricted stock

 

(1,334)

 

(1,700)

Net cash provided by (used in) financing activities

 

60,957

 

(13,305)

Effect of foreign exchange rate changes on cash

 

(2,269)

 

(776)

Net decrease in cash and cash equivalents

 

(2,758)

 

(3,922)

Cash and cash equivalents at beginning of period

 

22,463

 

23,131

Cash and cash equivalents at end of period

$

19,705

$

19,209

ALLIED MOTION TECHNOLOGIES INC.
Reconciliation of Non-GAAP Financial Measures
(In thousands)
(Unaudited)

In addition to reporting revenue and net income, which are U.S. generally accepted accounting principle (“GAAP”) measures, the Company presents Revenue excluding foreign currency exchange rate impacts, and EBITDA and Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, stock-based compensation expense, business development costs, and foreign currency gains/losses), which are non-GAAP measures.

The Company believes that Revenue excluding foreign currency exchange rate impacts is a useful measure in analyzing organic sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period.

The Company believes EBITDA and Adjusted EBITDA are often a useful measure of a Company’s operating performance and are a significant basis used by the Company’s management to evaluate and compare the core operating performance of its business from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense, business development costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company’s core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.

The Company’s calculation of Revenue excluding foreign currency exchange impacts for the three and nine months ended September 30, 2022 is as follows:

Three Months Ended

 

Nine Months Ended

September 30, 2022

 

September 30, 2022

Revenue as reported

$

134,405

 

$

371,912

Currency impact

 

7,173

 

 

15,577

Revenue excluding foreign currency exchange impacts

$

141,578

 

$

387,489

The Company’s calculation of Adjusted EBITDA for the three and nine months ended September 30, 2022 and 2021 is as follows:

Three Months Ended

Nine Months Ended

 

September 30,

September 30,

 

2022

 

 

2021

 

 

 

2022

 

 

2021

 

 

Net income

$

6,609

$

5,972

 

 

$

13,693

$

22,533

 

 

Interest expense

 

2,337

 

777

 

 

 

4,900

 

2,445

 

 

Provision (benefit) for income tax

 

2,508

 

1,950

 

 

 

4,878

 

(2,804

)

 

Depreciation and amortization

 

6,692

 

4,427

 

 

 

19,222

 

13,317

 

 

EBITDA

 

18,146

 

13,126

 

 

 

42,693

 

35,491

 

 

Stock compensation expense

 

1,262

 

 

1,303

 

 

 

3,752

 

3,100

 

 

Foreign currency (gain) loss

 

257

 

 

(69

)

 

 

54

 

(42

)

 

Business development costs

 

199

 

 

94

 

 

 

2,464

 

268

 

 

Adjusted EBITDA

$

19,864

$

14,454

 

 

$

48,963

$

38,817

 

 

ALLIED MOTION TECHNOLOGIES INC.
Reconciliation of GAAP Net Income and Diluted Earnings per Share to
Non-GAAP Adjusted Net Income and Diluted Earnings per Share
(In thousands, except per share data)
(Unaudited)

The Company’s calculation of Adjusted net income and Adjusted diluted earnings per share for the three and nine months ended September 30, 2022 and 2021 is as follows:

Three Months Ended

September 30,

 

2022

Per diluted
share

 

 

2021

 

Per diluted
share

Net income as reported

$

6,609

$

0.41

$

5,972

 

$

0.41

 

Non-GAAP adjustments, net of tax

Amortization of intangible assets - net

 

 

2,725

 

0.17

 

 

1,152

 

 

0.08

 

 

Foreign currency gain/ loss - net

 

 

197

 

0.01

 

 

(50

)

 

(0.00

)

 

Business development costs - net

 

152

 

0.01

 

72

 

 

0.00

 

Adjusted net income and diluted EPS

$

9,683

$

0.60

$

7,146

 

$

0.49

 

 

Weighted average diluted shares outstanding

 

16,169

 

14,502

 

Nine Months Ended

September 30,

 

2022

Per diluted
share

 

 

2021

 

Per diluted
share

Net income as reported

$

13,693

$

0.86

$

22,533

 

$

1.56

 

Non-GAAP adjustments, net of tax

Discrete income tax benefit

 

-

 

-

 

 

(7,373

)

 

(0.51

)

 

Amortization of intangible assets - net

 

 

7,417

 

0.47

 

 

3,468

 

 

0.24

 

 

Foreign currency gain/ loss - net

 

 

41

 

0.00

 

 

(30

)

 

(0.00

)

 

Business development costs - net

 

1,887

 

0.12

 

205

 

 

0.01

 

Adjusted net income and diluted EPS

$

23,039

$

1.45

$

18,803

 

$

1.30

 

 

Weighted average diluted shares outstanding

 

15,929

 

14,478

 

Adjusted net income and diluted EPS are defined as net income as reported, adjusted for certain items, including amortization of intangible assets and unusual non-recurring items. Adjusted net income and diluted EPS are not a measure determined in accordance with GAAP in the United States, and may not be comparable to the measure as used by other companies. Nevertheless, the Company believes that providing non-GAAP information, such as adjusted net income and diluted EPS are important for investors and other readers of the Company’s financial statements and assists in understanding the comparison of the current quarter’s and current year’s net income and diluted EPS to the historical periods’ net income and diluted EPS.

Investor:

Deborah K. Pawlowski / Craig P. Mychajluk

Kei Advisors LLC

716-843-3908 / 716-843-3832

dpawlowski@keiadvisors.com / cmychajluk@keiadvisors.com

Source: Allied Motion Technologies Inc.

FAQ

What was Allied Motion Technologies' revenue growth for Q3 2022?

Allied Motion Technologies reported a revenue growth of 30%, reaching a record $134.4 million for Q3 2022.

How much did the gross margin improve for Allied Motion in Q3 2022?

The gross margin improved to 32.2%, an increase of 130 basis points year-over-year.

What was the net income for Allied Motion in Q3 2022?

The net income for Allied Motion in Q3 2022 was $6.6 million, or $0.41 per diluted share.

What are the key factors contributing to Allied Motion's revenue increase?

Key factors include higher demand across target markets, organic growth, and sales from recent acquisitions.

What is the outlook for Allied Motion's tax rate for the full year 2022?

The company expects its effective income tax rate for full year 2022 to be approximately 25% to 27%.

Allient Inc.

:AMOT

AMOT Rankings

AMOT Latest News

AMOT Stock Data

550.91M
13.50M
16.55%
63%
0.38%
Electronic Components
Technology
Link
United States
Amherst